DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03726398 (ClinicalTrials.gov)	September 1, 2018	21/10/2018	CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH	CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated Interstitial Lung DiseasE and Pulmonary Hypertension (PH): The CRuSADE PH Study	Interstitial Lung Disease;Scleroderma;Pulmonary Hypertension	Drug: Opsumit 10 Mg Tablet	Franz Rischard, DO	National Jewish Health;University of Pittsburgh	Recruiting	18 Years	N/A	All	26	Phase 2;Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03726398
(ClinicalTrials.gov)

September 1, 2018

21/10/2018

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated Interstitial Lung DiseasE and Pulmonary Hypertension (PH): The CRuSADE PH Study

Interstitial Lung Disease;Scleroderma;Pulmonary Hypertension

Drug: Opsumit 10 Mg Tablet

Franz Rischard, DO

National Jewish Health;University of Pittsburgh

Recruiting

18 Years

N/A

All

Phase 2;Phase 3

United States